| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9k3754W |
| P356 | DOI | 10.1371/JOURNAL.PONE.0113754 |
| P932 | PMC publication ID | 4239117 |
| P698 | PubMed publication ID | 25412184 |
| P5875 | ResearchGate publication ID | 268873929 |
| P2093 | author name string | Jun Zhou | |
| Dandan Wang | |||
| Jiafang Fu | |||
| Bin Shi | |||
| Chunliang Wang | |||
| Wei Qian | |||
| Jianmei Wu | |||
| Leilei Wang | |||
| Chunshan Liu | |||
| Jihong Pan | |||
| Youming Zhu | |||
| Ziqing He | |||
| Genglin Zhang | |||
| Zongkun Jin | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Characterizing the cancer genome in lung adenocarcinoma | Q24649926 | ||
| Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis | Q24657188 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers | Q28115840 | ||
| Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers | Q28207853 | ||
| Protein tyrosine phosphatases in the human genome | Q28265924 | ||
| Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis | Q28472991 | ||
| Protein tyrosine phosphatases: from genes, to function, to disease | Q29614826 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. | Q34065944 | ||
| Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas | Q34178075 | ||
| Mutational analysis of the tyrosine phosphatome in colorectal cancers | Q34322220 | ||
| Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer | Q34444611 | ||
| Genomic and genetic alterations influence the progression of gastric cancer | Q34497423 | ||
| A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage | Q35626652 | ||
| Protein-tyrosine phosphatases and cancer | Q36430193 | ||
| Comparison of Cancer Incidence between China and the USA | Q36814359 | ||
| Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome | Q37377962 | ||
| Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma | Q37385138 | ||
| Recent patterns in gastric cancer: a global overview | Q39985871 | ||
| Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution | Q40098447 | ||
| Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays | Q40243352 | ||
| High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma | Q40296399 | ||
| Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis | Q40402337 | ||
| The selective reduction in PTPdelta expression in hepatomas | Q41051118 | ||
| Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs | Q41783160 | ||
| Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. | Q42806564 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | e113754 | |
| P577 | publication date | 2014-11-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma | |
| P478 | volume | 9 |
| Q42350797 | A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence |
| Q64244656 | Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance |
| Q36651966 | Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma |
| Q91729236 | PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin |
| Q47152563 | Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer |
| Q53269470 | Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia |
| Q38870961 | Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation |
| Q55260605 | The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma. |
| Q38979938 | miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis |
Search more.